Taiwan Industry Reports
Industry Type:   Title:  

 
Regenerative Medicine
2017-MarDoc #27026Industry Report (condensed version)US$100
Although the industry is expected to see a slight growth in output value, ranging from 3 percent to 5 percent, the industry is still in its embryonic stage.
Food Biotechnology Industry
2016-DecDoc #26450Industry Report (condensed version)US$75
China’s nutritional food improves and will contribute to a steady growth in the production value of Taiwan’s food biotechnology industry in 2017.
Regenerative Medicine Industry
2016-JunDoc #25563Industry Report (condensed version)US$75
The industry’s output value is expected to rise marginally by 3 – 5 percent year-on-year in the first half of 2016.
Agricultural Biotechnology Industry
2016-JanDoc #24872Industry Report (condensed version)US$75
In the first ten months of 2015, Taiwan’s exports of bottle orchid seedlings fell by 4.53 percent in value because of China’s ban on imports. However, other animal vaccines enjoyed a strong growth, and Taiwan’s effort to support the agricultural biotechnology industry lifted other animal vaccines industry.
Regenerative Medicine
2015-OctDoc #24378Industry Report (condensed version)US$75
Both output and sales values of the industry will still contract in the third quarter of 2015 from the same period a year earlier as a consequence of weaker-than-expected export to China and a decline in the prices of cotton yarn products.
Western Medicines and Biopharmaceuticals
2015-SepDoc #24268Industry Report (condensed version)US$75
The industry sales would rise in value in the final quarter of 2015 from a year earlier, and growth would range between 1 percent and 3 percent.
Raw Material Medicine Manufacturing
2015-AugDoc #24137Industry Report (condensed version)US$75
Despite poor domestic sales of the industry, firms within the industry continue to launch new products. Additionally, customers in Europe, India, and Japan keep restocking, suggesting the industry’s sales growth would range between 2 percent and 4 percent in the second half of 2015.
Food Biotechnology Industry
2015-MarDoc #23538Industry Report (condensed version)US$75
The industry’s production value is expected to rise by 6 to 9 percent in 2015, thanks to stable growth in the domestic market, expansion of export markets, and plans by a number of firms to engage in high margin capsule and tablet nutritional supplements.
Agricultural Biotechnology
2015-JanDoc #23312Industry Report (condensed version)US$75
Industry conditions are expected to improve in the first half of 2015. However, because of shrinking export markets, growth in the production value of plant tissue culture seedlings may rise by 5 percent to 7 percent from the same period a year earlier.
Biotechnology Service Industry
2015-JanDoc #23308Industry Report (condensed version)US$75
With a raft of newly developed pharmaceuticals, dietary supplements and cosmetics reaching the market worldwide, Taiwan is expected to see growth in biotechnology industry in the first half of 2015.
 First  Previous  Next  Last  In  1  /  4  Page  (Find  32  records)
 





Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543